Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 4/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27862443 | 0.84 | PPARG (0.48) | EPHX1PPARGPPARAL3MBTL1POLB | |
| SCHEMBL25268462 | 0.82 | EPHX1 (0.55) | EPHX1PPARGPPARAL3MBTL1POLB | |
| SCHEMBL44800 | 0.81 | L3MBTL1 (0.56) | EPHX1PPARGPPARAL3MBTL1POLB | |
| SCHEMBL5181984 | 0.81 | TRPA1 (0.50) | EPHX1PPARGPPARAL3MBTL1POLB | |
| SCHEMBL7050743 | 0.78 | POLB (0.51) | PPARGPPARAL3MBTL1POLBATM | |
| SCHEMBL3705344 | 0.76 | PPARG (0.47) | EPHX1PPARGPPARAL3MBTL1POLB | |
| SCHEMBL6954426 | 0.76 | PPARG (0.49) | EPHX1PPARGPPARAL3MBTL1POLB | |
| SCHEMBL1855157 | 0.76 | CYP1A2 (0.53) | PPARGPPARAPOLBSMN1; SMN2NPSR1 | |
| SCHEMBL15141726 | 0.76 | L3MBTL1 (0.55) | EPHX1PPARGPPARAL3MBTL1POLB | |
| SCHEMBL11770018 | 0.75 | CYP2C19 (0.50) | EPHX1PPARGPPARAL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1339692-A1 | NOVEL COMPOUNDS FOR USE AS HIV PROTEASE INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2003-09-03 | — | — | EP | disclosed |
| WO-2002042277-A1 | NOVEL COMPOUNDS FOR USE AS HIV PROTEASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-05-30 | — | — | WO | disclosed |